Nicotinamide Riboside (NR): On Its Own or in a Synergistic Formula?

Nicotinamide riboside (NR) has evolved from a laboratory compound into one of the most studied supplements in the field of cellular vitality. And as the market matures, one question becomes unavoidable among those who do their research before buying: does it make sense to take NR on its own, or are the benefits amplified by combining it with other ingredients?

There is no single answer. The choice between a single-ingredient NR supplement and a synergistic formula depends on the user's profile, the wellness goal being pursued and, above all, on what the current scientific evidence does—and does not—have to say about each combination.

This article examines both approaches rigorously: what the science says about NR on its own, which combinations are backed by clinical data, which are speculative, and how to make an informed decision. Because in supplementation, more is not always better.

What Nicotinamide Riboside Is and Why NAD+ Matters

Nicotinamide riboside (NR) is a form of vitamin B3 authorized as a Novel Food in the European Union and one of the most efficient precursors of NAD+ (nicotinamide adenine dinucleotide), a coenzyme present in every cell in the body. NAD+ is essential for cellular energy production, DNA repair and the regulation of proteins such as sirtuins—enzymes associated with the control of cellular aging—and PARPs, which are involved in the response to genetic damage. If you want to dig deeper into what NAD+ is and why it matters so much for cellular vitality, you can read our guide on what NAD+ is and how to look after it.

The problem is that NAD+ levels decline progressively with age. Studies in human tissue have documented substantial reductions: an analysis of human skin samples found a significant negative correlation between age and NAD+ levels, with substantial drops in older adults compared with younger adults. Neuroimaging studies have confirmed similar patterns in brain tissue. Different methodologies, a consistent conclusion: NAD+ falls over the years.

This is where NR comes in. Unlike other forms of vitamin B3 such as niacin or nicotinamide, NR is converted into NAD+ through a relatively direct metabolic pathway: NR → NMN (nicotinamide mononucleotide) → NAD+. Metabolic tracing studies suggest that part of the conversion may also occur via nicotinamide as an intermediate. This conversion efficiency is one of the reasons NR has accumulated more human clinical trials than any other NAD+ precursor.

The first clinical trial to show that oral NR supplementation raises blood NAD+ levels in humans was published by Trammell et al. in 2016 in the journal Nature Communications. Since then, more than a dozen controlled trials have replicated this finding with doses ranging from 250 mg to 1,000 mg daily.

The Case for Single-Ingredient NR: What the Clinical Evidence Says

Before assessing whether a synergistic formula adds value, it helps to understand what NR can do on its own. The available evidence is more solid than many consumers realize.

Raising Blood NAD+: Level A Evidence

A systematic review published in Nutrients that analyzed the available controlled clinical trials concluded that NR supplementation consistently and significantly raises blood NAD+ levels in healthy adults. The average increase documented across studies ranges from 40% to 90% above baseline, depending on the dose and duration of supplementation.

Mitochondrial Function and Energy Metabolism

A randomized, double-blind, placebo-controlled, crossover clinical trial in healthy middle-aged and older adults (n=24; Martens et al., 2018, Nature Communications) showed that 1,000 mg/day of NR for 6 weeks raised NAD+ levels in peripheral blood mononuclear cells by 60% compared with placebo. Confirmation that NR also raises NAD+ at the muscle-tissue level—through analysis of the metabolome and transcriptomics of skeletal muscle in biopsies—comes from a later independent study (Elhassan et al., 2019).

Blood Pressure and Vascular Function

The same research group recorded, as a non-prespecified secondary finding, a reduction in systolic blood pressure in a subgroup of participants with elevated blood pressure. The authors themselves noted that this result should be interpreted with caution given the exploratory nature of the analysis, the small size of the subgroup and the risk of false positives inherent to post-hoc subgroup analyses. Research on NR and vascular function remains active, although there are not yet clinical trials specifically designed to evaluate this effect as a primary endpoint. This result describes an exploratory analysis from a single study and does not constitute a property attributable to any product.

Inflammation and Oxidative Stress

A 21-day study in older adults (Elhassan et al., 2019, Cell Reports) showed that 1,000 mg/day of NR produced changes in the transcriptomic profile of skeletal muscle with anti-inflammatory signatures, and reductions were observed in circulating inflammatory markers such as IL-6 and TNF-α. The authors themselves pointed out that the sample size (n=12 in the NR group) limits the generalizability of these results, and that the reduction in inflammatory markers was a secondary finding in a study not primarily designed to measure inflammation.

Limitations of the Current Evidence on NR Alone

It would be dishonest not to mention the limitations. Most clinical trials with NR have small sample sizes (n < 100), short durations (4–12 weeks) and use intermediate biomarkers—such as blood NAD+ levels—rather than hard clinical endpoints such as mortality, disease incidence or long-term quality of life. The question of whether raising NAD+ translates into clinically meaningful long-term benefits in healthy humans remains open.

This does not invalidate the use of NR, but it does require precision: the evidence supports that NR raises NAD+ safely and consistently. The associated functional benefits are promising, though still in the process of being consolidated.

What a Synergistic Formula Is and Which Combinations Exist

A synergistic formula combines NR with one or more active ingredients with the aim of enhancing, complementing or broadening its effects on NAD+ metabolism or other pathways related to cellular vitality.

The most common combinations on the market and in the scientific literature are:

NR + Resveratrol

Resveratrol is a polyphenol that directly activates sirtuins, the same proteins that NAD+ activates indirectly. The synergy hypothesis is that, while NR raises NAD+ levels—the “fuel” for sirtuins—resveratrol acts as an “accelerator” of these enzymes. This combination has generated considerable scientific interest, driven by a line of academic research on sirtuins and NAD+. However, the resveratrol field has undergone critical reappraisal: its oral bioavailability is very low (roughly 1% of the ingested dose reaches systemic circulation), and human studies have produced more modest results than those obtained in animal models. This does not invalidate the synergy hypothesis with NR, but it does call for calibrated expectations.

There is currently no controlled clinical trial that has specifically evaluated the NR+resveratrol combination in humans with a design that allows the combined formula to be compared against NR alone.

NR + Pterostilbene

Pterostilbene is a resveratrol analog with greater oral bioavailability. It shares the sirtuin-activation mechanism and has more favorable pharmacokinetics. Dellinger et al. (2017, PMID 29184669) carried out a double-blind trial with 120 adults that evaluated the NR+pterostilbene (NRPT) combination against placebo, observing a dose-dependent increase in blood NAD+ levels. The study did not include an NR-only arm, so on its own it does not allow any conclusion about the superiority of the combination over NR alone. Some researchers consider pterostilbene a superior alternative to resveratrol for oral use, although the specific clinical evidence on the combination with NR remains limited.

NR + Quercetin

Quercetin is a flavonoid with senolytic properties—that is, it may help eliminate senescent cells, those that have stopped dividing but remain metabolically active and secrete inflammatory factors. The combination of NR with quercetin is based on the hypothesis that raising NAD+ may enhance the autophagy and apoptosis mechanisms that quercetin activates. The direct clinical evidence is preliminary.

NR + TMG (Trimethylglycine or Betaine)

This is perhaps the combination with the strongest mechanistic support at present. When NR raises NAD+ levels, the processes of NAD+ synthesis and catabolism generate metabolites such as methylnicotinamide, which consume methyl groups from the cellular pool. If the availability of methyl groups is insufficient, the body might compensate by reducing other critical methylation reactions, such as those of DNA. TMG acts as a methyl-group donor, which could theoretically offset this effect. This hypothesis has a plausible biochemical basis, but direct clinical evidence in humans on the NR+TMG combination and its effect on DNA methylation patterns is still nonexistent in the published, peer-reviewed literature.

NR + Coenzyme Q10

CoQ10 is an essential component of the mitochondrial electron transport chain. The synergy hypothesis with NR is based on the idea that both act on mitochondrial function through complementary pathways: NR increases the NAD+ available to the dehydrogenases of the Krebs cycle, while CoQ10 optimizes the efficiency of the respiratory chain. The clinical evidence on this specific combination is scarce, although both ingredients individually are backed by solid clinical trials.

How Do You Evaluate the Evidence for a Combined Formula?

Before deciding whether a synergistic formula is superior to single-ingredient NR, there is a fundamental methodological problem that affects almost all research on supplement combinations. It is worth understanding.

The Attribution Problem in Studies of Combined Formulas

When a study evaluates a formula containing NR + resveratrol + pterostilbene + CoQ10 and observes a positive effect, it is impossible to determine which ingredient—or which combination of ingredients—produced that effect. This is known as the attribution problem and is a critical limitation of most studies on combined formulas.

To establish real synergy, a clinical trial needs at least four treatment arms: placebo, ingredient A alone, ingredient B alone, and A+B. Only then is it possible to determine whether the effect of the combination is additive (equal to the sum of the individual effects), synergistic (greater than the sum) or antagonistic (less than the sum). This kind of factorial design is costly and rare in supplement research. For reference, the most robust quantitative figure available in the field—the 60% increase in NAD+ with NR alone—comes from a study of NR as the sole active ingredient; the published trials on the NR+pterostilbene combination were compared against placebo, not against NR alone, so they do not allow any additional effect attributable to the combination to be quantified.

What This Means in Practice

It means that most “synergy” claims in the supplement market are reasonable mechanistic hypotheses, not facts demonstrated in clinical trials with a factorial design. This does not invalidate them—a solid mechanistic hypothesis has value—but it does require communicating them with the appropriate language: “may enhance,” “it is hypothesized that,” “preliminary studies suggest.”

An informed consumer should distinguish between:

• Demonstrated synergy: the effect of the combination has been compared directly with each component separately in a controlled clinical trial in humans. Examples in the NAD+ field: practically nonexistent with a complete factorial design.
• Plausible mechanistic synergy: the mechanisms of action of the ingredients are complementary and the hypothesis of a positive interaction has support in cell or animal models. Example: NR + TMG (DNA methylation).
• Marketing synergy: the combination is presented as synergistic without any verifiable mechanistic or clinical support.

The Golden Rule for Evaluating a Combined Formula

Before assuming that a combined formula is superior to NR alone, ask: is there a controlled clinical trial that directly compares the combined formula with single-ingredient NR, with the same sample size and the same duration? If the answer is no—and in most cases it is—you are looking at a reasonable hypothesis, not at evidence of superiority.

When to Choose Single-Ingredient NR: Profiles and Situations

Single-ingredient NR is the most suitable option in the following scenarios:

1. When the Goal Is to Establish a Baseline

If it is the first time someone is supplementing with an NAD+ precursor, starting with NR alone makes it possible to assess the individual response without confounding variables. Some users experience changes in sleep, energy or muscle recovery in the first few weeks. If several ingredients are taken at the same time, it is impossible to attribute any change to NR specifically.

2. When Taking Other Medications or Supplements

People undergoing pharmacological treatment should be especially cautious with combined formulas. Each additional ingredient introduces a potential for interaction. Single-ingredient NR has a well-documented safety profile in clinical trials with healthy adults and with chronic conditions (Dollerup et al., 2018; Remie et al., 2020). Combined formulas have safety profiles that are less studied in populations with comorbidities. Always consult your doctor or pharmacist if you are undergoing any pharmacological treatment before adding any supplement.

3. When the Dose Matters

Clinical trials with NR have used specific, well-documented doses: 250 mg, 500 mg and 1,000 mg daily. In a combined formula, the NR dose may be diluted by the presence of other ingredients, resulting in a suboptimal amount of NR. If the goal is to replicate the doses used in clinical studies, the single-ingredient format offers greater control.

4. When Formulation Transparency Is a Priority

Some manufacturers use “proprietary blends” in their combined formulas, which makes it impossible to know the exact dose of each ingredient. A single-ingredient NR supplement with a declared dose offers greater transparency and allows the consumer—and their doctor or pharmacist—to assess the supplementation precisely.

5. In People Over 60 Without Specific Conditions

For the general goal of maintaining the NAD+ levels associated with physiological aging, the available evidence with NR alone is solid enough. There is no clinical evidence to show that a combined formula produces better results in this population than single-ingredient NR at appropriate doses.

When a Synergistic Formula May Make Sense: Profiles and Situations

Synergistic formulas can be a reasonable option in specific contexts, provided the combination is mechanistically grounded and the additional ingredients have evidence of their own.

1. When There Is a Well-Defined Secondary Goal

If a person is looking not only to raise NAD+ but also to address another aspect of cellular wellness—for example, oxidative stress, low-grade chronic inflammation or mitochondrial function—a formula that combines NR with ingredients backed by their own evidence in those areas can be coherent. The key is that each additional ingredient has independent evidence, not just the hypothesis of synergy with NR.

2. When Co-Supplementation with TMG Is Justified

As explained earlier, the NR + TMG combination has the strongest mechanistic basis of all the available combinations. For people who supplement with high doses of NR (≥ 500 mg/day) over the long term, co-supplementation with TMG may be prudent to preserve the availability of methyl groups. This is one of the few combinations where the biochemical rationale is robust enough to be considered in practice, although the direct clinical evidence in humans remains limited.

3. In the Context of Supervised Cellular-Vitality Protocols

Some doctors who specialize in preventive medicine and healthy aging design protocols that combine NR with other ingredients within the framework of an individualized assessment that includes biomarkers (blood NAD+ levels, DNA methylation analysis, inflammatory markers). In this context, a combined formula may make sense as part of a personalized and monitored protocol.

4. When Adherence Is a Decisive Factor

From a practical standpoint, taking a single supplement that combines several ingredients can improve adherence compared with taking multiple capsules separately. If the real alternative is not “NR alone vs. NR + other ingredients” but “NR + other ingredients in one capsule vs. taking nothing,” the combined formula may be the more realistic option.

What a Synergistic Formula Should NOT Do

A combined formula should not include ingredients without their own evidence or a plausible mechanism of action in relation to NAD+. The presence of multiple ingredients at suboptimal doses—what is known as “pixie dusting”—is a warning sign: the manufacturer may be adding ingredients to justify a premium price without any of them reaching the clinically supported dose.

Comparison Table: Single-Ingredient NR vs. Synergistic Formula

The following table summarizes the key criteria to guide the decision between the two approaches:

How to Use This Table

There is no universal answer. The optimal decision depends on the individual profile, wellness goals, the medication situation and the level of evidence each person considers sufficient to act on. What is universal is the need to read labels carefully, verify the dose of each ingredient and consult a healthcare professional before starting any supplementation protocol.

Safety, Side Effects and Contraindications

NR has a well-documented safety profile. The clinical trials published to date, with doses of up to 1,000 mg/day for periods of up to 12 weeks, have not reported serious adverse effects. The most frequently described side effects are mild and transient: nausea, gastrointestinal discomfort and skin flushing in some cases, although the latter effect is significantly less frequent with NR than with niacin (Trammell et al., 2016; Martens et al., 2018).

A safety trial with 120 adults that evaluated the NR + pterostilbene (NRPT) combination against placebo (Dellinger et al., 2017) found no significant differences in safety parameters—liver, kidney and hematological function—after 8 weeks. For NR as a monotherapy, the trials by Dollerup et al. (2018) and Remie et al. (2020) reported good tolerability, with mild and transient adverse effects.

Groups Who Should Consult Their Doctor Before Supplementing with NR

• People with diagnosed liver or kidney disease.
• People being treated with medications that affect NAD+ metabolism or DNA methylation.
• Pregnant or breastfeeding women (absence of safety data in these populations).
• People with a history of cancer, especially hormone-dependent tumors. In the absence of specific clinical data in these populations, consulting the oncologist or attending physician before starting any supplementation is recommended.
• People with disorders of vitamin B3 metabolism.

Additional Considerations for Combined Formulas

Each additional ingredient in a synergistic formula introduces its own safety profile and its own contraindications. Resveratrol, for example, may inhibit liver enzymes (CYP2C9) involved in the metabolism of anticoagulants such as warfarin, which could potentiate their effect. This interaction, although not widely documented in clinical trials, has been described in case reports and pharmacological reviews, and warrants caution in people on anticoagulants. Quercetin may interfere with the absorption of certain antibiotics. TMG may raise homocysteine levels in people with certain genetic variants of folate metabolism.

This does not mean that combined formulas are dangerous, but rather that they require a more careful assessment, especially in people with chronic conditions or on multiple medications.

Remember: before starting any supplementation protocol, consult your doctor or pharmacist. This information is for educational purposes and does not replace individualized professional advice.

The choice between single-ingredient NR and a synergistic formula is not a question of which is objectively better, but of which is more suitable for each person, at each moment and for each wellness goal.

Single-ingredient NR has the most solid clinical evidence base available for an NAD+ precursor: more than a dozen controlled trials in humans, a well-documented safety profile and a clearly established effective dose. For most people looking to maintain the NAD+ levels associated with physiological aging, NR alone is a scientifically grounded option.

Synergistic formulas can add value when the combination is mechanistically justified, the additional ingredients have evidence of their own and the doses of each component are transparent and appropriate. The NR + TMG combination is, as of today, the one with the strongest biochemical foundation, although direct clinical evidence in humans remains limited.

What has no scientific justification is assuming that more ingredients equals more efficacy. In supplementation, the complexity of a formula is not synonymous with superiority. Evidence, transparency and the appropriate dose are the criteria that should guide any informed decision.

If you have any doubts about which approach is most suitable for your situation, consult your doctor or pharmacist before starting any supplementation protocol.